Mixed-methods study explores vaccine hesitancy in religious officials, revealing key concerns and implications.
Vaccine hesitancy has risen globally and in Türkiye. Religious officials often act as community opinion leaders; their views may shape acceptance of vaccination and newborn bloodspot screening (NBS). We conducted a cross-sectional study among Muslim religious officials in Erzurum, Türkiye (n = 200). A 47-item questionnaire captured sociodemographics, health-service use/satisfaction, attitudes to childhood/adult vaccines and newborn bloodspot screening, and the 21-item Turkish Vaccine Hesitancy Scale (higher scores = higher hesitancy). Open-ended item elicited qualitative comments. Quantitative comparisons used t-tests/one-way ANOVA (α = 0.05). Qualitative data underwent inductive thematic analysis (Braun-Clarke); two independent coders achieved Cohen's κ = 0.80. Mean vaccine hesitancy score was 62.9 ± 11.4. Scores did not differ by sociodemographics (p > .05). Lower satisfaction with health services was associated with higher hesitancy (overall p = .004). Hesitancy varied by attitudes toward adult vaccination (p = .003), childhood vaccination (p = .002), and NBS support (p = .004) - with lower scores among supporters. Only 19% were aware of the Organization of Islamic Cooperation (OIC) fatwa on vaccination; awareness was not associated with hesitancy (p > .05). Thematic analysis (n = 40 textual responses) yielded five themes: safety/adverse-effect concerns (27.5%); information & service-process experience (22.5%); perceived benefit/effectiveness (bipolar) (20.0%); privacy/biomaterial (NBS) (17.5%); and fertility/genetic-harm beliefs (12.5%).Among religious officials, vaccine hesitancy appeared to cluster around safety and institutional trust, reinforced by privacy/biomaterial, fertility/genetic, and effectiveness narratives. Interventions should prioritize content transparency (including halal and safety information), process transparency for NBS (storage/secondary use/disposal policies), co-delivery of messages by physicians and religious officials, proactive risk communication, and brief, targeted training modules.
No takes yet. Share an insight, caveat, or question.
Daharlı et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: